EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Exploring heterogeneity: a dive into preclinical models of cancer cachexia

Francielly Morena iD, Ana Regina Cabrera iD, Nicholas P Greene iD

American Journal of Physiology-Cell Physiology · 01.08.2024 · 327 (2) · C310-C328

DOI: 10.1152/ajpcell.00317.2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.08.2024. Verfasst von Francielly Morena und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cachexia Research Laboratory, Exercise Science Research Center, Department of Health, Human Performance and Recreation, University of Arkansas, Fayet…. Hauptthemen laut MEDLINE: Cachexia, Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cachexia (CC) is a multifactorial and complex syndrome experienced by up to 80% of patients with cancer and implicated in ∼40% of cancer-related deaths. Given its significant impact on patients’ quality of life and prognosis, there has been a growing emphasis on elucidating the underlying mechanisms of CC using preclinical models. However, the mechanisms of cachexia appear to differ across several variables including tumor type and model and biologic variables such as sex. These differences may be exacerbated by variance in experimental approaches and data reporting. This review examines literature spanning from 2011 to March 2024, focusing on common preclinical models of CC, including Lewis Lung Carcinoma, pancreatic KPC, and colorectal colon-26 and Apc min/+ models. Our analysis reveals considerable heterogeneity in phenotypic outcomes, and investigated mechanisms within each model, with particular attention to sex differences that may be exacerbated through methodological differences. Although searching for unified mechanisms is critical, we posit that effective treatment approaches are likely to leverage the heterogeneity presented by the tumor and pertinent biological variables to direct specific interventions. In exploring this heterogeneity, it becomes critical to consider methodological and data reporting approaches to best inform further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsAnimalsHumansDisease Models, AnimalFemaleMaleSex Factors

Stichwörter der Autor:innen

ApcMin/+KPCLewis lung carcinoma (LLC)biological sexcolon-26 (C26)

Autor:innen und Institutionen

  • Cachexia Research Laboratory, Exercise Science Research Center, Department of Health, Human Performance and Recreation, University of Arkansas, Fayetteville, Arkansas, United States.

ORCID-Profile: Francielly Morena, Ana Regina Cabrera, Nicholas P Greene

Förderung

  • NIAMS NIH HHS
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Zitieren

APA

Morena, F., Cabrera, A. R., & Greene, N. P. (2024). Exploring heterogeneity: a dive into preclinical models of cancer cachexia. American Journal of Physiology-Cell Physiology, 327(2), C310-C328. https://doi.org/10.1152/ajpcell.00317.2024

Vancouver

Morena F, Cabrera AR, Greene NP. Exploring heterogeneity: a dive into preclinical models of cancer cachexia. American Journal of Physiology-Cell Physiology. 2024;327(2):C310-C328. doi:10.1152/ajpcell.00317.2024

BibTeX
@article{Morena2024,
  author = {Morena, Francielly and Cabrera, Ana Regina and Greene, Nicholas P},
  title = {Exploring heterogeneity: a dive into preclinical models of cancer cachexia},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2024},
  volume = {327},
  number = {2},
  pages = {C310--C328},
  doi = {10.1152/ajpcell.00317.2024}
}
Kostenlos starten →